Nod-like receptors in intestinal homeostasis, inflammation, and cancer

Journal of Leukocyte Biology

Volumn 90, Issue 3, 2011, Pages 471-482

  Werts, Catherine ^a   Rubino, Stephen ^b   Ling, Arthur ^b   Girardin, Stephen E ^b   Philpott, Dana J ^b  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Colon cancer; Crohn's disease; Toll like receptors

Indexed keywords

MEMBRANE RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; TOLL LIKE RECEPTOR;

AUTOPHAGY; CHRONIC INFLAMMATION; COLITIS; CROHN DISEASE; DENDRITIC CELL; GASTROINTESTINAL TRACT; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION CONTROL; INNATE IMMUNITY; INTESTINE CANCER; INTESTINE EPITHELIUM CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; HOMEOSTASIS; HUMANS; INFLAMMATION; INTESTINAL NEOPLASMS; NOD SIGNALING ADAPTOR PROTEINS;

EID: 80052356829     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0411183     Document Type: Review

References (78)

1. Eberl, G., Lochner, M. (2009) The development of intestinal lymphoid tissues at the interface of self and microbiota. Mucosal Immunol. 2, 478-485.
2. Bouskra, D., Brezillon, C., Berard, M., Werts, C., Varona, R., Boneca, I. G., Eberl, G. (2008) Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507-510.
3. Clarke, T. B., Davis, K. M., Lysenko, E. S., Zhou, A. Y., Yu, Y., Weiser, J. N. (2010) Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 16, 228-231.
4. Dharancy, S., Body-Malapel, M., Louvet, A., Berrebi, D., Gantier, E., Gosset, P., Viala, J., Hollebecque, A., Moreno, C., Philpott, D. J., Girardin, S. E., Sansonetti, P. J., Desreumaux, P., Mathurin, P., Dubuquoy, L. (2010) Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control. Gastroenterology 138, 1546-1556.
5. Bevins, C. L., Stange, E. F., Wehkamp, J. (2009) Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype. Gut 58, 882-883, discussion 883-884.
6. Wehkamp, J., Salzman, N. H., Porter, E., Nuding, S., Weichenthal, M., Petras, R. E., Shen, B., Schaeffeler, E., Schwab, M., Linzmeier, R., Feathers, R. W., Chu, H., Lima Jr., H., Fellermann, K., Ganz, T., Stange, E. F., Bevins, C. L. (2005) Reduced Paneth cell α-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 102, 18129-18134.
7. Simms, L. A., Doecke, J. D., Walsh, M. D., Huang, N., Fowler, E. V., Radford-Smith, G. L. (2008) Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 57, 903-910.
8. Fritz, T., Niederreiter, L., Tilg, H., Blumberg, R. S., Kaser, A. (2010) Controversy over NOD2, inflammation, and defensins. Inflamm. Bowel Dis. 16, 1996-1998.
9. Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G., Flavell, R. A. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734.
10. Petnicki-Ocwieja, T., Hrncir, T., Liu, Y. J., Biswas, A., Hudcovic, T., Tlaskalova-Hogenova, H., Kobayashi, K. S. (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. USA 106, 15813-15818.
11. Rehman, A., Sina, C., Gavrilova, O., Hasler, R., Ott, S., Baines, J. F., Schreiber, S., Rosenstiel, P. (2011) Nod2 is essential for temporal development of intestinal microbial communities. Gut, E-pub ahead of print.
12. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L. G., Gratadoux, J. J., Blugeon, S., Bridonneau, C., Furet, J. P., Corthier, G., Grangette, C., Vasquez, N., Pochart, P., Trugnan, G., Thomas, G., Blottiere, H. M., Dore, J., Marteau, P., Seksik, P., Langella, P. (2008) Fecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105, 16731-16736.
13. Hirota, S. A., Ng, J., Lueng, A., Khajah, M., Parhar, K., Li, Y., Lam, V., Potentier, M. S., Ng, K., Bawa, M., McCafferty, D. M., Rioux, K. P., Ghosh, S., Xavier, R. J., Colgan, S. P., Tschopp, J., Muruve, D., Macdonald, J. A., Beck, P. L. (2011) NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm. Bowel Dis. 17, 1359-1372.
14. Martinon, F., Agostini, L., Meylan, E., Tschopp, J. (2004) Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14, 1929-1934.
15. Pan, Q., Mathison, J., Fearns, C., Kravchenko, V. V., Da Silva Correia, J., Hoffman, H. M., Kobayashi, K. S., Bertin, J., Grant, E. P., Coyle, A. J., Sutterwala, F. S., Ogura, Y., Flavell, R. A., Ulevitch, R. J. (2007) MDP-induced interleukin-1β processing requires Nod2 and CIAS1/NALP3. J. Leukoc. Biol. 82, 177-183.
16. Barreau, F., Madre, C., Meinzer, U., Berrebi, D., Dussaillant, M., Merlin, F., Eckmann, L., Karin, M., Sterkers, G., Bonacorsi, S., Lesuffleur, T., Hugot, J. P. (2010) Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyer's patches. Gut 59, 207-217.
17. Chabot, S., Wagner, J. S., Farrant, S., Neutra, M. R. (2006) TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium. J. Immunol. 176, 4275-4283.
18. Shaw, M. H., Reimer, T., Sanchez-Valdepenas, C., Warner, N., Kim, Y. G., Fresno, M., Nunez, G. (2009) T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii. Nat. Immunol. 10, 1267-1274.
19. Penack, O., Smith, O. M., Cunningham-Bussel, A., Liu, X., Rao, U., Yim, N., Na, I. K., Holland, A. M., Ghosh, A., Lu, S. X., Murphy, G. F., Brandl, K., van den Brink, M. R. (2009) NOD2 regulates hematopoietic cell function during graft-versus-host disease. J. Exp. Med. 206, 2101-2110.
20. Penack, O., Holler, E., van den Brink, M. R. (2010) Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. Blood 115, 1865-1872.
21. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R. (2004) Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
22. Fukata, M., Michelsen, K. S., Eri, R., Thomas, L. S., Hu, B., Lukasek, K., Nast, C. C., Lechago, J., Xu, R., Naiki, Y., Soliman, A., Arditi, M., Abreu, M. T. (2005) Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1055-G1065.
23. Araki, A., Kanai, T., Ishikura, T., Makita, S., Uraushihara, K., Iiyama, R., Totsuka, T., Takeda, K., Akira, S., Watanabe, M. (2005) MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40, 16-23.
24. Watanabe, T., Asano, N., Murray, P. J., Ozato, K., Tailor, P., Fuss, I. J., Kitani, A., Strober, W. (2008) Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Invest. 118, 545-559.
25. Bauer, C., Duewell, P., Mayer, C., Lehr, H. A., Fitzgerald, K. A., Dauer, M., Tschopp, J., Endres, S., Latz, E., Schnurr, M. (2010) Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 59, 1192-1199.
26. Zaki, M. H., Boyd, K. L., Vogel, P., Kastan, M. B., Lamkanfi, M., Kanneganti, T. D. (2010) The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379-391.
27. Allen, I. C., TeKippe, E. M., Woodford, R. M., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., Ting, J. P. (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207, 1045-1056.
28. Dupaul-Chicoine, J., Yeretssian, G., Doiron, K., Bergstrom, K. S., McIntire, C. R., LeBlanc, P. M., Meunier, C., Turbide, C., Gros, P., Beauchemin, N., Vallance, B. A., Saleh, M. (2010) Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32, 367-378.
29. Pizarro, T. T., Michie, M. H., Bentz, M., Woraratanadharm, J., Smith Jr., M. F., Foley, E., Moskaluk, C. A., Bickston, S. J., Cominelli, F. (1999) IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J. Immunol. 162, 6829-6835.
30. Loher, F., Bauer, C., Landauer, N., Schmall, K., Siegmund, B., Lehr, H. A., Dauer, M., Schoenharting, M., Endres, S., Eigler, A. (2004) The interleukin-1 β-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation. J. Pharmacol. Exp. Ther. 308, 583-590.
31. Bauer, C., Loher, F., Dauer, M., Mayer, C., Lehr, H. A., Schonharting, M., Hallwachs, R., Endres, S., Eigler, A. (2007) The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-α mRNA expression. Dig. Dis. Sci. 52, 1642-1652.
32. Siegmund, B., Fantuzzi, G., Rieder, F., Gamboni-Robertson, F., Lehr, H. A., Hartmann, G., Dinarello, C. A., Endres, S., Eigler, A. (2001) Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1264-R1273.
33. Sivakumar, P. V., Westrich, G. M., Kanaly, S., Garka, K., Born, T. L., Derry, J. M., Viney, J. L. (2002) Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50, 812-820.
34. Ishikura, T., Kanai, T., Uraushihara, K., Iiyama, R., Makita, S., Totsuka, T., Yamazaki, M., Sawada, T., Nakamura, T., Miyata, T., Kitahora, T., Hibi, T., Hoshino, T., Watanabe, M. (2003) Interleukin-18 overproduction exacerbates the development of colitis with markedly infiltrated macrophages in interleukin-18 transgenic mice. J. Gastroenterol. Hepatol. 18, 960-969.
35. Siegmund, B., Lehr, H. A., Fantuzzi, G., Dinarello, C. A. (2001) IL-1 β-converting enzyme (caspase-1) in intestinal inflammation. Proc. Natl. Acad. Sci. USA 98, 13249-13254.
36. Saha, S., Qi, J., Wang, S., Wang, M., Li, X., Kim, Y. G., Nunez, G., Gupta, D., Dziarski, R. (2009) PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation. Cell Host Microbe 5, 137-150.
37. Wang, Z. M., Li, X., Cocklin, R. R., Wang, M., Fukase, K., Inamura, S., Kusumoto, S., Gupta, D., Dziarski, R. (2003) Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidase. J. Biol. Chem. 278, 49044-49052.
38. Duerr, C. U., Salzman, N. H., Dupont, A., Szabo, A., Normark, B. H., Normark, S., Locksley, R. M., Mellroth, P., Hornef, M. W. (2011) Control of intestinal Nod2-mediated peptidoglycan recognition by epitheliumassociated lymphocytes. Mucosal Immunol. 4, 325-334.
39. Biswas, A., Liu, Y. J., Hao, L., Mizoguchi, A., Salzman, N. H., Bevins, C. L., Kobayashi, K. S. (2010) Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc. Natl. Acad. Sci. USA 107, 14739-14744.
40. Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Memet, S., Huerre, M. R., Coyle, A. J., DiStefano, P. S., Sansonetti, P. J., Labigne, A., Bertin, J., Philpott, D. J., Ferrero, R. L. (2004) Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5, 1166-1174.
41. Girardin, S. E., Tournebize, R., Mavris, M., Page, A. L., Li, X., Stark, G. R., Bertin, J., DiStefano, P. S., Yaniv, M., Sansonetti, P. J., Philpott, D. J. (2001) CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2, 736-742.
42. Werts, C., le Bourhis, L., Liu, J., Magalhaes, J. G., Carneiro, L. A., Fritz, J. H., Stockinger, S., Balloy, V., Chignard, M., Decker, T., Philpott, D. J., Ma, X., Girardin, S. E. (2007) Nod1 and Nod2 induce CCL5/RANTES through the NF-κB pathway. Eur. J. Immunol. 37, 2499-2508.
43. Watanabe, T., Asano, N., Fichtner-Feigl, S., Gorelick, P. L., Tsuji, Y., Matsumoto, Y., Chiba, T., Fuss, I. J., Kitani, A., Strober, W. (2010) NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Invest. 120, 1645-1662.
44. He, J. Q., Saha, S. K., Kang, J. R., Zarnegar, B., Cheng, G. (2007) Specificity of TRAF3 in its negative regulation of the noncanonical NF-κ B pathway. J. Biol. Chem. 282, 3688-3694.
45. Sabbah, A., Chang, T. H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P. H., Xiang, Y., Bose, S. (2009) Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10, 1073-1080.
46. Saleh, M., Vaillancourt, J. P., Graham, R. K., Huyck, M., Srinivasula, S. M., Alnemri, E. S., Steinberg, M. H., Nolan, V., Baldwin, C. T., Hotchkiss, R. S., Buchman, T. G., Zehnbauer, B. A., Hayden, M. R., Farrer, L. A., Roy, S., Nicholson, D. W. (2004) Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429, 75-79.
47. Saleh, M., Mathison, J. C., Wolinski, M. K., Bensinger, S. J., Fitzgerald, P., Droin, N., Ulevitch, R. J., Green, D. R., Nicholson, D. W. (2006) Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 440, 1064-1068.
48. LeBlanc, P. M., Yeretssian, G., Rutherford, N., Doiron, K., Nadiri, A., Zhu, L., Green, D. R., Gruenheid, S., Saleh, M. (2008) Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity. Cell Host Microbe 3, 146-157.
49. Le Bourhis, L., Magalhaes, J. G., Selvanantham, T., Travassos, L. H., Geddes, K., Fritz, J. H., Viala, J., Tedin, K., Girardin, S. E., Philpott, D. J. (2009) Role of Nod1 in mucosal dendritic cells during Salmonella pathogenicity island 1-independent Salmonella enterica serovar typhimurium infection. Infect. Immun. 77, 4480-4486.
50. Geddes, K., Rubino, S., Streutker, C., Cho, J. H., Magalhaes, J. G., Le Bourhis, L., Selvanantham, T., Girardin, S. E., Philpott, D. J. (2010) Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model. Infect. Immun. 78, 5107-5115.
51. Bruno, V. M., Hannemann, S., Lara-Tejero, M., Flavell, R. A., Kleinstein, S. H., Galan, J. E. (2009) Salmonella typhimurium type III secretion effectors stimulate innate immune responses in cultured epithelial cells. PLoS Pathog. 5, e1000538.
52. Huett, A., Xavier, R. J. (2010) Autophagy at the gut interface: mucosal responses to stress and the consequences for inflammatory bowel diseases. Inflamm. Bowel Dis. 16, 152-174.
53. Levine, B., Mizushima, N., Virgin, H. W. (2011) Autophagy in immunity and inflammation. Nature 469, 323-335.
54. Bortoluci, K. R., Medzhitov, R. (2010) Control of infection by pyroptosis and autophagy: role of TLR and NLR. Cell. Mol. Life Sci. 67, 1643-1651.
55. Franke, A., McGovern, D. P., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125.
56. Cadwell, K., Liu, J. Y., Brown, S. L., Miyoshi, H., Loh, J., Lennerz, J. K., Kishi, C., Kc, W., Carrero, J. A., Hunt, S., Stone, C. D., Brunt, E. M., Xavier, R. J., Sleckman, B. P., Li, E., Mizushima, N., Stappenbeck, T. S., Virgin, H. W. t. (2008) A key role for autophagy and the autophagy gene ATG16L1 in mouse and human intestinal Paneth cells. Nature 456, 259-263.
57. Travassos, L. H., Carneiro, L. A., Ramjeet, M., Hussey, S., Kim, Y. G., Magalhaes, J. G., Yuan, L., Soares, F., Chea, E., Le Bourhis, L., Boneca, I. G., Allaoui, A., Jones, N. L., Nunez, G., Girardin, S. E., Philpott, D. J. (2010) Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11, 55-62.
58. Cooney, R., Baker, J., Brain, O., Danis, B., Pichulik, T., Allan, P., Ferguson, D. J., Campbell, B. J., Jewell, D., Simmons, A. (2010) NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 16, 90-97.
59. Homer, C. R., Richmond, A. L., Rebert, N. A., Achkar, J. P., McDonald, C. (2010) ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 139, 1630-1641.
60. Melmed, G. Y. (2009) Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm. Bowel Dis. 15, 1410-1416.
61. Grivennikov, S. I., Greten, F. R., Karin, M. (2010) Immunity, inflammation, and cancer. Cell 140, 883-899.
62. Rakoff-Nahoum, S., Medzhitov, R. (2009) Toll-like receptors and cancer. Nat. Rev. Cancer 9, 57-63.
63. Kurzawski, G., Suchy, J., Kladny, J., Grabowska, E., Mierzejewski, M., Jakubowska, A., Debniak, T., Cybulski, C., Kowalska, E., Szych, Z., Domagala, W., Scott, R. J., Lubinski, J. (2004) The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res. 64, 1604-1606.
64. Papaconstantinou, I., Theodoropoulos, G., Gazouli, M., Panoussopoulos, D., Mantzaris, G. J., Felekouras, E., Bramis, J. (2005) Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int. J. Cancer 114, 433-435.
65. Roberts, R. L., Gearry, R. B., Allington, M. D., Morrin, H. R., Robinson, B. A., Frizelle, F. A. (2006) Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Res. 66, 2532-2535.
66. Möckelmann, N., von Schonfels, W., Buch, S., von Kampen, O., Sipos, B., Egberts, J. H., Rosenstiel, P., Franke, A., Brosch, M., Hinz, S., Roder, C., Kalthoff, H., Folsch, U. R., Krawczak, M., Schreiber, S., Broring, C. D., Tepel, J., Schafmayer, C., Hampe, J. (2009) Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer. BMC Gastroenterol. 9, 79.
67. Tuupanen, S., Alhopuro, P., Mecklin, J. P., Jarvinen, H., Aaltonen, L. A. (2007) No evidence for association of NOD2 R702W and G908R with colorectal cancer. Int. J. Cancer 121, 76-79.
68. Lakatos, P. L., Hitre, E., Szalay, F., Zinober, K., Fuszek, P., Lakatos, L., Fischer, S., Osztovits, J., Gemela, O., Veres, G., Papp, J., Ferenci, P. (2007) Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer 7, 54.
69. Tian, Y., Li, Y., Hu, Z., Wang, D., Sun, X., Ren, C. (2010) Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis. Int. J. Colorectal Dis. 25, 161-168.
70. Grubman, A., Kaparakis, M., Viala, J., Allison, C., Badea, L., Karrar, A., Boneca, I. G., Le Bourhis, L., Reeve, S., Smith, I. A., Hartland, E. L., Philpott, D. J., Ferrero, R. L. (2010) The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides. Cell. Microbiol. 12, 626-639.
71. Rosenstiel, P., Hellmig, S., Hampe, J., Ott, S., Till, A., Fischbach, W., Sahly, H., Lucius, R., Folsch, U. R., Philpott, D., Schreiber, S. (2006) Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell. Microbiol. 8, 1188-1198.
72. Hnatyszyn, A., Szalata, M., Stanczyk, J., Cichy, W., Slomski, R. (2010) Association of c.802C>T polymorphism of NOD2/CARD15 gene with the chronic gastritis and predisposition to cancer in H. pylori infected patients. Exp. Mol. Pathol. 88, 388-393.
73. Da Silva Correia, J., Miranda, Y., Austin-Brown, N., Hsu, J., Mathison, J., Xiang, R., Zhou, H., Li, Q., Han, J., Ulevitch, R. J. (2006) Nod1-dependent control of tumor growth. Proc. Natl. Acad. Sci. USA 103, 1840-1845.
74. Chen, G. Y., Shaw, M. H., Redondo, G., Nunez, G. (2008) The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res. 68, 10060-10067.
75. Arthur, J. C., Jobin, C. (2011) The struggle within: microbial influences on colorectal cancer. Inflamm. Bowel Dis. 17, 396-409.
76. Uronis, J. M., Muhlbauer, M., Herfarth, H. H., Rubinas, T. C., Jones, G. S., Jobin, C. (2009) Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE 4, e6026.
77. Zaki, M. H., Vogel, P., Body-Malapel, M., Lamkanfi, M., Kanneganti, T. D. (2010) IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J. Immunol. 185, 4912-4920.
78. Villani, A. C., Lemire, M., Fortin, G., Louis, E., Silverberg, M. S., Collette, C., Baba, N., Libioulle, C., Belaiche, J., Bitton, A., Gaudet, D., Cohen, A., Langelier, D., Fortin, P. R., Wither, J. E., Sarfati, M., Rutgeerts, P., Rioux, J. D., Vermeire, S., Hudson, T. J., Franchimont, D. (2009) Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat. Genet. 41, 71-76.